Has Beth Kerneklian received payments from drug or device companies?

Yes. Drug and device makers reported $1,653 in general payments to Beth Kerneklian across 58 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Beth Kerneklian did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Beth Kerneklian come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Beth Kerneklian

Physician Assistant · Lakewood Ranch, FLNPI 1073760146

Payments from drug & device makers

$1,653in general payments, 2019–2025

Across 58 payments — averaging $28.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Relievant Medsystems, Inc.$449
Novo Nordisk$204
AbbVie$197
Medtronic$163
Nalu Medical, Inc.$127
Si-bone, Inc.$70
plus $442 from 16 others

What the payments were for

Travel & lodging$28717%
Food & beverage$1,36683%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Relievant Medsystems, Inc.	5	$449
Novo Nordisk	11	$204
AbbVie	6	$197
Medtronic	8	$163
Nalu Medical, Inc.	2	$127
Si-bone, Inc.	2	$70
Antares Pharma, Inc.	3	$57
Azurity Pharmaceuticals, Inc.	2	$41
Boston Scientific	2	$39
Abbott	2	$39
Idorsia Pharmaceuticals US Inc	2	$34
Fidia Pharma USA Inc.	2	$31
Kowa Pharmaceuticals America, Inc.	1	$31
Lilly USA, LLC	2	$28
Vertos Medical, Inc.	1	$25
Phadia US Inc.	1	$20
Pfizer	1	$19
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$17
Exact Sciences	1	$16
Collegium Pharmaceutical, Inc.	1	$15
Tolmar, Inc.	1	$14
Currax Pharmaceuticals LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Intracept$573
Nalu Neurostimulation System$111

How this compares

$1,653 in reported general payments places this provider in the 70th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MounjaroTirzepatide	13	$13,530
OzempicSemaglutide	14	$13,195
Atorvastatin Calcium	26	$358
Albuterol Sulfate HfaAlbuterol Sulfate	16	$306
Ezetimibe	11	$299
Fluticasone Propionate	15	$209
Gabapentin	17	$194
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	12	$163
Amlodipine Besylate	23	$163
Simvastatin	11	$162
Metoprolol Succinate	15	$132
Methylprednisolone	17	$122
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	15	$121
Levothyroxine Sodium	21	$107
Metformin Hcl	15	$87

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Lilly USA, LLCMounjaro	$28	$13,53013 claims
Novo NordiskOzempic	$204	$13,19514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Lakewood Ranch

Melissa BeachyLakewood Ranch$105K
Richard MarshallPort Orange$988K
Audrey BeckerSt Augustine$689K
Kevin WilliamsTampa$647K
Brian BonomoLecanto$559K
Melissa SingletonOcala$482K
Reeli ReinuMaitland$427K
Jeanelle KingMiami$424K
Risha BellomoOrlando$397K
Jason BergerClearwater$344K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →